Published in J Autism Dev Disord on June 01, 2003
Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders. J Autism Dev Disord (2011) 0.82
Self-injurious behaviour in autistic children: a neuro-developmental theory of social and environmental isolation. Psychopharmacology (Berl) (2013) 0.78
Psychotropic drug treatments for people with autism and other developmental disorders: a primer for practicing behavior analysts. Behav Anal Pract (2010) 0.77
Assessing the Impact of Psychotropic Medication Changes on Challenging Behavior of Individuals with Intellectual Disabilities. Int J Dev Disabil (2016) 0.75
Ethical Considerations for Interdisciplinary Collaboration with Prescribing Professionals. Behav Anal Pract (2017) 0.75
Toward a functional analysis of self-injury. J Appl Behav Anal (1994) 45.91
Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures. Am J Ment Retard (2001) 2.23
An evaluation of methylphenidate as a potential establishing operation for some common classroom reinforcers. J Appl Behav Anal (1997) 1.97
A preliminary analysis of interactive effects between common classroom contingencies and methylphenidate. J Appl Behav Anal (1997) 1.69
A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry (1998) 1.47
An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatry (1998) 1.43
A comparison of multiple reinforcer assessments to identify the function of maladaptive behavior. J Appl Behav Anal (2002) 1.41
Further analysis of the separate and interactive effects of methylphenidate and common classroom contingencies. J Appl Behav Anal (1999) 1.34
Assessing independent and interactive effects of behavioral and pharmacologic interventions for a client with dual diagnoses. J Behav Ther Exp Psychiatry (1989) 1.14
Self-injurious behavior: gene-brain-behavior relationships. Ment Retard Dev Disabil Res Rev (2001) 1.03
Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study. Acta Psychiatr Scand (1993) 0.96
Risperidone and explosive aggressive autism. J Autism Dev Disord (1997) 0.86
Using analog baselines to assess the effects of naltrexone on self-injurious behavior. Res Dev Disabil (1999) 0.85
Case study: risperidone treatment of children and adolescents with developmental disorders. J Am Acad Child Adolesc Psychiatry (1996) 0.79
Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults. J Autism Dev Disord (1997) 0.78
Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities. Am J Ment Retard (1994) 0.77
Risperidone in PDD. J Am Acad Child Adolesc Psychiatry (1998) 0.75
Behavior analysis of pharmacological and contingency management interventions for self-injury. J Behav Ther Exp Psychiatry (1986) 0.75
Neural mechanisms associated with food motivation in obese and healthy weight adults. Obesity (Silver Spring) (2009) 1.88
Neural mechanisms underlying food motivation in children and adolescents. Neuroimage (2005) 1.48
A comparison of multiple reinforcer assessments to identify the function of maladaptive behavior. J Appl Behav Anal (2002) 1.41
Neural mechanisms underlying hyperphagia in Prader-Willi syndrome. Obesity (Silver Spring) (2006) 1.30
A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J Child Adolesc Psychopharmacol (2005) 1.16
ANKRD11 gene deletion in a 17-year-old male. Clin Dysmorphol (2011) 1.09
Positive behavior support and applied behavior analysis: a familial alliance. Behav Modif (2008) 1.09
Increasing response diversity in children with autism. J Appl Behav Anal (2010) 1.03
Longitudinal assessment of stereotypic, proto-injurious, and self-injurious behavior exhibited by young children with developmental delays. Am J Ment Retard (2005) 1.01
Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice. Brain Res (2010) 1.00
Mass Screening for Severe Problem Behavior among Infants and Toddlers In Peru. J Ment Health Res Intellect Disabil (2012) 0.96
A clinical report and further delineation of the 14q32 deletion syndrome. Clin Dysmorphol (2011) 0.95
Crewmember performance before, during, and after spaceflight. J Exp Anal Behav (2005) 0.95
Risk factors for self-injury, aggression, and stereotyped behavior among young children at risk for intellectual and developmental disabilities. Am J Intellect Dev Disabil (2014) 0.94
A crossover study of risperidone in children, adolescents and adults with mental retardation. J Autism Dev Disord (2006) 0.93
Differential acquisition of lever pressing in inbred and outbred mice: comparison of one-lever and two-lever procedures and correlation with differences in locomotor activity. J Exp Anal Behav (2005) 0.91
Genetics and mitochondrial abnormalities in autism spectrum disorders: a review. Curr Genomics (2011) 0.89
Developmental effects of dietary n-3 fatty acids on activity and response to novelty. Physiol Behav (2010) 0.88
Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders. J Child Adolesc Psychopharmacol (2005) 0.86
Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature. J Autism Dev Disord (2007) 0.86
Rate-decreasing effects of the atypical neuroleptic risperidone attenuated by conditions of reinforcement in a woman with mental retardation. J Appl Behav Anal (2003) 0.86
Behavioral, structural and molecular changes following long-term hippocampal IL-1β overexpression in transgenic mice. J Neuroimmune Pharmacol (2011) 0.86
Effects of risperidone on aberrant behavior in persons with developmental disabilities: II. Social validity measures. Am J Ment Retard (2002) 0.85
IL1RAPL1 gene deletion as a cause of X-linked intellectual disability and dysmorphic features. Eur J Med Genet (2011) 0.85
An 18-year follow-up report on an infant with a duplication of 9q34. Am J Med Genet A (2010) 0.83
Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis. Am J Ment Retard (2004) 0.81
The overt aggression scale for rating aggression in outpatient youth with autistic disorder: preliminary findings. J Neuropsychiatry Clin Neurosci (2005) 0.80
Designs and analyses of psychotropic and behavioral interventions for the treatment of problem behavior among people with intellectual and developmental disabilities. Am J Intellect Dev Disabil (2011) 0.80
Brief report: altered social behavior in isolation-reared Fmr1 knockout mice. J Autism Dev Disord (2013) 0.80
Assessment and treatment in autism spectrum disorders: a focus on genetics and psychiatry. Autism Res Treat (2012) 0.79
Comparison of biological specimens and DNA collection methods for PCR amplification and microarray analysis. Clin Chem Lab Med (2013) 0.79
12-year-old boy with a 4q35.2 microdeletion and involvement of MTNR1A, FAT1, and F11 genes. Clin Dysmorphol (2012) 0.79
A behavior-analytic conceptualization of the side effects of psychotropic medication. Behav Anal (2004) 0.79
Differences in methylphenidate dose response between periadolescent and adult rats in the familiar arena-novel alcove task. J Pharmacol Exp Ther (2010) 0.79
Methylphenidate attenuates rats' preference for a novel spatial stimulus introduced into a familiar environment: assessment using a force-plate actometer. J Neurosci Methods (2010) 0.78
Dopamine re-uptake inhibitor GBR-12909 induction of aberrant behaviors in animal models of dopamine dysfunction. Int J Dev Neurosci (2002) 0.77
Use of a force-plate actometer for detecting and quantifying vertical leaping induced by amphetamine in BALB/cJ mice, but not in C57BL/6J, DBA/2J, 129X1/SvJ, C3H/HeJ, and CD-1 mice. J Neurosci Methods (2005) 0.77
Nociceptor and age specific effects of REM sleep deprivation induced hyperalgesia. Behav Brain Res (2004) 0.77
Much improved outcome with gabapentin-divalproex combination in adults with bipolar disorders and developmental disabilities. J Clin Psychopharmacol (2006) 0.76
A multimethod assessment of anxiety and problem behavior in children with autism spectrum disorders and intellectual disability. Am J Intellect Dev Disabil (2013) 0.76
Multimodal evaluation of risperidone for destructive behavior: functional analysis, direct observations, rating scales, and psychiatric impressions. Exp Clin Psychopharmacol (2002) 0.76
Serotonin₂A/C receptors mediate the aggressive phenotype of TLX gene knockout mice. Behav Brain Res (2013) 0.76
Use of an antecedent analysis and a force sensitive platform to compare stereotyped movements and motor tics. Am J Ment Retard (2005) 0.76
The progression of severe behavior disorder in young children with intellectual and developmental disabilities. Res Dev Disabil (2013) 0.75
The effects of directive and nondirective prompts on noncompliant vocal behavior exhibited by a child with autism. J Appl Behav Anal (2005) 0.75
Cocaine's effects on the discrimination of simple and complex auditory stimuli by baboons. Pharmacol Biochem Behav (2002) 0.75
Fixed ratio discrimination training increases in vivo striatal dopamine in neonatal 6-OHDA-lesioned rats. Pharmacol Biochem Behav (2002) 0.75
Parametric analysis of thermal preference following sleep deprivation in the rat. Neurosci Lett (2010) 0.75
A retrospective study of amitriptyline in youth with autism spectrum disorders. J Autism Dev Disord (2013) 0.75
Examining risperidone use in those diagnosed with autism 1 year after FDA approval. J Clin Psychiatry (2010) 0.75
Efficacy and safety of selective serotonin reuptake inhibitors in the treatment of depression in children and adolescents: practitioner review. Clin Drug Investig (2006) 0.75
Kinetic assessment of the effects of task difficulty, microencephaly, and a response manipulandum alteration on the rate of fixed-ratio discrimination acquisition. Exp Clin Psychopharmacol (2002) 0.75
Varied effects of conventional antiepileptics on responding maintained by negative versus positive reinforcement. Physiol Behav (2007) 0.75
Cocaine's effects on detection, discrimination, and identification of auditory stimuli by baboons. Pharmacol Biochem Behav (2003) 0.75
Training of child and adolescent psychiatry fellows in autism and intellectual disability. Autism (2013) 0.75
Should clinical trial research of psychotropic medication in autism control for gastrointestinal symptoms? J Clin Pharmacol (2014) 0.75